Services & Solutions
/
Drug Development
/
Drug Metabolism & Pharmacokinetics (DMPK)
/
In Vivo Services
With more than 20 years of drug metabolism and pharmacokinetics (DMPK) expertise, our team of scientists can deliver all of the data needed for your compound optimization and candidate selection.
In vivo, pharmacokinetic studies play an important role in new drug discovery and development stages. These studies provide critical data in the absorption of a drug candidate, distribution into issues and metabolic pathways, and how it’s excreted from the body.
Discover the following In Vivo services at Frontage
Pharmacokinetics
Pharmacokinetics studies to investigate new chemical entities.
MIST – Metabolites in Safety Testing
A key component of human risk assessment for drug candidates.
Radiolabeled Studies
QWBA Studies
Evaluating the time course of elimination for total radioactivity from tissues in animals.
Human C14 AME (hAME) Study Services
Full-Service Radiolabeled hAME Studies
Resources To Consider
fact-sheet
DMPK Services Fact Sheet
At Frontage, we offer extensive drug metabolism and pharmacokinetic capabilities for new c…
fact-sheet
Human C14 AME (hAME) Services
Frontage offers full-service radiolabeled human C14 AME (hAME) studies to support your dru…
webinar
Quantitative Whole-Body Autoradiography (QWBA) and Radiation…
This webinar gives an overview of QWBA and hAME study services, an understanding of the gu…
fact-sheet
Microbiome Services Fact Sheet
At Frontage, our scientific team has over a decade of experience in Microbiome to help you…
application-notes
MIST Application Note
Regulatory agencies have made recommendations on when and how to identify and characterize…
